Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PfSPZ Vaccine in HIV Negative and Positive Tanzanian Adults
NCT03420053Phase 1Completed
- Sponsor
- Sanaria Inc.
- Start
- Feb 2018
- Primary completion
- Aug 2018
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of Sanaria PfSPZ Vaccine in Malaria (5 arms), sponsored by Sanaria Inc. Primary endpoints: Safety of PfSPZ Vaccine - solicited symptoms, Safety of PfSPZ Vaccine - unsolicited symptoms and 3 more. Started Feb 2018; status: completed.
02
Drugs
Sanaria PfSPZ Vaccine
03
Conditions
Malaria
Beyond the preview
Go deeper on NCT03420053.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03420053.